Zum Inhalt springenSkip to content

Eosinophils ​

Disclaimer: Information on this page is for educational purposes. Consult a physician to interpret your test results. Lissa Health helps track biomarker trends but does not replace medical advice.

What This Test Measures ​

Eosinophils participate in allergic reactions and defense against parasites. They release mediators that drive inflammation in allergy and asthma.

Eosinophilia (>0.5 × 10⁹/L or >4–5%) occurs in allergic rhinitis, asthma, parasitic infections, drug reactions, and hypereosinophilic syndromes.

Marked eosinophilia (>1.5 × 10⁹/L) requires evaluation for parasitic infections, malignancy, and endocrine disorders.

Normal Ranges ​

GroupReference Range
Men1–4% (<0.5 × 10⁹/L)
Women1–4% (<0.5 × 10⁹/L)
Children1–6%

Reference ranges may vary by laboratory and assay method.

Causes of High Levels ​

  • Allergic diseases (asthma, eczema, rhinitis)
  • Parasitic infections (ascariasis, toxocariasis)
  • Drug hypersensitivity
  • Eosinophilic esophagitis
  • Hypereosinophilic syndrome

Causes of Low Levels ​

  • Acute stress, corticosteroids
  • Cushing syndrome
  • Hyperadrenalism
  • Eosinopenia is rarely clinically significant

Test Preparation ​

  • No preparation required
  • Report allergies and travel history (parasites)
BiomarkerRelationship
White Blood CellsTotal leukocyte count
BasophilsOther granulocytes in allergy
C-Reactive Protein (CRP)Rule out infectious inflammation

FAQ ​

How often should I take this test? ​

With allergy and asthma — during flares; with CBC — annually.

What should I do if my result is abnormal? ​

Eosinophilia >1.5 × 10⁹/L warrants parasite, allergen, and hematologic evaluation.


Last updated: June 2026

ООО «Алвита» — разработчик Lissa Health